首页> 外国专利> composition and use of a long-acting oral endoparasiticide bioadhesive gel based on doramectin

composition and use of a long-acting oral endoparasiticide bioadhesive gel based on doramectin

机译:多拉菌素的长效口服杀体内寄生虫生物胶的组成和用途

摘要

The present invention relates to the composition of an oral bioadhesive endoparasiticide gel based on doramectin, having a high degree of adhesion to equine oral mucosa and having a sweet flavour greatly facilitating the dosing thereof, procedures for the preparation and the utilisation thereof. Gastrointestinal helminthosis is a parasitic condition caused by nematodes of diverse families occassioning serious gastrointestinal disorders in equine livestock. Control of this illness is of great importance and advantageously achievable through the employment of appropiate antihelmintic agents such as doramectin, being is a chemical compound widely administered by parenteral 1 route and infrequently by oral route in liquid form due to the organoleptic and physicochemical characteristics of the compositions known up to the present. The present invention demonstrates that it is possible to administer doramectin in the pharmaceutical form of an oral gel at concentrations of up to 5.0% weight/volume, overcoming the organoleptic and physicochemical restrictions of the compositions known up to the present.
机译:本发明涉及基于多拉菌素的口服生物粘附性内杀寄生虫剂凝胶的组合物,其对马口腔粘膜具有高度的粘附性,并且具有甜味,极大地促进了其剂量给药,其制备方法和用途。胃肠蠕虫病是由各种家庭的线虫在马畜中发生严重胃肠道疾病引起的寄生虫病。控制这种疾病非常重要,并且可以通过使用适当的抗蠕虫药(例如多拉克丁)来实现控制,该药物是非肠道1途径广泛使用的化合物,由于其感官和理化特性,很少以口服形式以液体形式口服迄今为止已知的组合物。本发明证明可以以高达5.0%重量/体积的浓度以口服凝胶的药物形式施用多拉菌素,从而克服了迄今为止已知的组合物的感官和物理化学限制。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号